Market revenue in 2020 | USD 28.7 million |
Market revenue in 2027 | USD 51.3 million |
Growth rate | 8.7% (CAGR from 2020 to 2027) |
Largest segment | Surgical |
Fastest growing segment | Surgical |
Historical data covered | 2016 - 2019 |
Base year for estimation | 2020 |
Forecast period covered | 2021 - 2027 |
Quantitative units | Revenue in USD million |
Market segmentation | Surgical, Non-surgical |
Key market players worldwide | Pfizer Inc, Cadila Pharmaceuticals, Geistlich Pharma, Healthy Life Pharma, R N Laboratories, Basic Pharma Lifesciences |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to peri-implantitis market will help companies and investors design strategic landscapes.
Surgical was the largest segment with a revenue share of 57.49% in 2020. Horizon Databook has segmented the Latin America peri-implantitis market based on surgical, non-surgical covering the revenue growth of each sub-segment from 2016 to 2027.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America peri-implantitis market, including forecasts for subscribers. This continent databook contains high-level insights into Latin America peri-implantitis market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account